Klastersky J - Search Results

1

Anticancer chemotherapy in a patient with prior history of acute intermittent porphyria. A case report and review of the literature.

Forget F, Awada A, Klastersky J. Forget F, et al. Among authors: klastersky j. Support Care Cancer. 2001 Sep;9(6):465-6. doi: 10.1007/s005200000232. Support Care Cancer. 2001. PMID: 11585274

2

Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC).

Klastersky J, Awada A. Klastersky J, et al. Crit Rev Oncol Hematol. 2012 Jan;81(1):49-57. doi: 10.1016/j.critrevonc.2011.02.002. Epub 2011 Mar 10. Crit Rev Oncol Hematol. 2012. PMID: 21396829 Review.

3

[Gemcitabine: a new chemotherapy agent for solid cancers].

Klastersky J, Awada A. Klastersky J, et al. Rev Med Brux. 1997 Oct;18(5):328-34. Rev Med Brux. 1997. PMID: 9441329 Review. French.

4

Prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers.

Awada A, Gil T, Sales F, Dubuisson M, Vereecken P, Klastersky J, Moerman C, de Valeriola D, Piccart MJ. Awada A, et al. Among authors: klastersky j. Anticancer Drugs. 2004 Jun;15(5):499-502. doi: 10.1097/01.cad.0000127331.29310.8a. Anticancer Drugs. 2004. PMID: 15166625 Clinical Trial.

5

The use of low-energy laser (LEL) for the prevention of chemotherapy- and/or radiotherapy-induced oral mucositis in cancer patients: results from two prospective studies.

Genot-Klastersky MT, Klastersky J, Awada F, Awada A, Crombez P, Martinez MD, Jaivenois MF, Delmelle M, Vogt G, Meuleman N, Paesmans M. Genot-Klastersky MT, et al. Among authors: klastersky j. Support Care Cancer. 2008 Dec;16(12):1381-7. doi: 10.1007/s00520-008-0439-8. Epub 2008 May 6. Support Care Cancer. 2008. PMID: 18458964 Clinical Trial.

6

Predictive factors for cancer-associated thrombosis in a large retrospective single-center study.

Haltout J, Awada A, Paesmans M, Moreau M, Klastersky J, Machiels G, Ignatiadis M, Kotecki N. Haltout J, et al. Among authors: klastersky j. Support Care Cancer. 2019 Apr;27(4):1163-1170. doi: 10.1007/s00520-018-4602-6. Epub 2019 Jan 4. Support Care Cancer. 2019. PMID: 30610431

7

Prevention of febrile neutropenia in chemotherapy-treated cancer patients: Pegylated versus standard myeloid colony stimulating factors. Do we have a choice?

Klastersky J, Awada A. Klastersky J, et al. Crit Rev Oncol Hematol. 2011 Apr;78(1):17-23. doi: 10.1016/j.critrevonc.2010.02.005. Epub 2010 Mar 12. Crit Rev Oncol Hematol. 2011. PMID: 20227290 Review.

8

[New trends in the management of common solid malignant tumors].

Klastersky J, Awada A. Klastersky J, et al. Rev Med Brux. 2005 Sep-Oct;26(5):425-32. Rev Med Brux. 2005. PMID: 16318095 French.

9

[Multiple neoplasms: etiological problems and possibilities for prevention].

Awada A, Klastersky J. Awada A, et al. Among authors: klastersky j. Rev Med Brux. 1992 Sep;13(7):239-42. Rev Med Brux. 1992. PMID: 1410966 Review. French.

10

Febrile neutropenia: a critical review of the initial management.

Klastersky J, Awada A, Paesmans M, Aoun M. Klastersky J, et al. Crit Rev Oncol Hematol. 2011 Jun;78(3):185-94. doi: 10.1016/j.critrevonc.2010.03.008. Epub 2010 Apr 21. Crit Rev Oncol Hematol. 2011. PMID: 20413323 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

555 results

Search Page

Filters